OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Commerce. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
Click here to read the articles and download the PDF
How drugmakers can better harness real-world evidence to drive their clinical and commercial objectives, while also providing greater clarity for healthcare providers and improved access to therapy for the patients they serve.
While new forms of pharmacy continue to surface beyond brick-and-mortar retail, a look at what is driving this shift in perspective—and "pharmacies of the future"—is warranted.
Methods that pharma companies can use to make the hub more personalized and experiential.
December 08, 2023
The rise in demand represents the third consecutive month of year-on-year growth.
FDA approves bluebird bio’s Lyfgenia and Vertex Pharmaceuticals' and CRISPR Therapeutics’ Casgevy for the treatment of sickle cell disease, which affects approximately 100,000 people in the United States.
Study analyzes and predicts how conditions in research and development can be predicted via computer simulation.
PrEPVacc tested two different combinations of vaccines to determine whether either can prevent HIV infection in populations at risk of acquiring the virus.
December 07, 2023
December's installment reinforces the publication's commitment to covering the latest updates on patient support.
Introducing a new style and feel to Pharma Commerce.
An independent Data Monitoring Committee found that Keytruda in combination with chemotherapy followed by Keytruda plus Lynparza did not produce an improved overall survival benefit vs. Keytruda in combination with chemotherapy followed by Keytruda plus a placebo in patients with metastatic squamous non-small cell lung cancer.
Back in Boston, Pharma Commerce tackles all things logistics at LogiPharma USA.
Will result from Medicare reforms, despite increased drug uptake.
December 06, 2023